recombin
measl
virus
rmv
base
live
attenu
measl
vaccin
strain
mvb
express
antigen
clade
b
gener
revers
genet
recombin
express
singl
doubl
antigen
rmvhiv
genet
highli
stabl
human
diploid
cell
product
process
virus
essenti
similar
parent
mv
strain
yield
compar
end
titer
immun
tgmice
differ
regimen
formul
show
potent
humor
cellular
immun
respons
mv
hiv
antigen
recombin
mvhiv
express
gag
protein
confer
protect
immun
tgmice
highdos
pseudochalleng
recombin
vaccinia
viru
addit
rmvhiv
boost
antihiv
antibodi
presenc
preexist
antivector
antibodi
human
immunodefici
virus
hiv
remain
global
health
problem
unpreced
dimens
sinc
discoveri
year
ago
hiv
alreadi
caus
estim
million
death
worldwid
gener
profound
demograph
chang
heavili
affect
countri
global
estim
million
peopl
live
hiv
averag
million
newli
infect
peopl
everi
year
report
annual
despit
effort
prevent
therapi
program
million
death
estim
everi
year
correl
protect
hiv
infect
persist
yet
defin
quest
prophylact
vaccin
remain
major
goal
fight
aid
ideal
hiv
vaccin
induc
neutral
antibodi
block
establish
infect
cellmedi
immun
contain
escap
viru
infect
addit
vaccin
safe
feasibl
manufactur
larg
scale
novel
technolog
employ
collect
develop
vaccin
among
replic
defici
viral
vector
like
modifi
vaccinia
ankara
canarypox
adenovirus
live
attenu
viral
vector
like
mv
addit
nonvir
dna
protein
formul
also
employ
howev
failur
merck
clinic
studi
use
recombin
express
gagpolnef
led
scientif
commun
critic
address
safeti
technolog
vector
system
origin
exist
vaccin
mv
vector
deriv
live
attenu
moraten
vaccin
mvbv
zuniga
et
al
prepar
mv
vaccin
excel
safeti
record
inject
aerosol
vaccin
strongli
activ
differ
arm
immun
system
cellular
humor
mucos
singl
two
lowdos
inject
persist
antibodi
ctl
shown
long
year
vaccin
addit
mv
genom
transloc
nucleu
avoid
viral
genom
integr
host
cell
genom
ad
safeti
profil
vaccin
revers
genet
system
mv
establish
allow
insert
express
addit
transgen
viral
genom
paper
show
rmv
express
singl
andor
multipl
gene
remain
stabl
induc
humor
cellular
immun
respons
transgen
mice
retain
efficaci
measl
cell
cultiv
use
media
supplement
fetal
bovin
serum
fb
stabli
transfect
rescu
cell
line
adapt
media
requir
cell
line
supplement
mgml
antibiot
geneticin
invitrogen
vero
cell
african
green
monkey
kidney
maintain
neaa
media
supplement
fb
lglutamin
mgml
gentamycin
mgml
plasmid
encod
clade
b
gagpol
gene
kindli
obtain
dr
g
nabel
vaccin
research
center
vrc
nih
usa
gene
optim
human
codon
usag
cytoplasm
tail
transmembran
domain
cleavag
site
fusion
domain
delet
yield
secret
form
moreov
obtain
fusion
intermediatelik
configur
region
encod
interheptad
space
addit
delet
addit
sequenc
delet
hypervari
loop
perform
enhanc
exposur
conserv
epitop
therefor
increas
chanc
induc
neutral
antibodi
gagpol
construct
gp
repres
synthet
gene
encod
gagpol
fusion
protein
optim
induc
potent
cellular
immun
respons
critic
function
polderiv
enzym
inactiv
mutagenesi
safeti
reason
pbcgag
plasmid
code
codonoptim
clade
b
gag
protein
alon
gag
kindli
receiv
feinberg
emori
univers
atlanta
usa
plasmid
p
clone
version
moraten
berna
mv
vaccin
strain
addit
transcript
unit
posit
p
gene
posit
h
l
fig
engin
gene
code
gp
amplifi
pcr
origin
plasmid
pcr
product
subclon
uniqu
site
mlui
aatii
p
p
result
plasmid
p
p
p
p
similarli
plasmid
contain
two
transgen
gener
ligat
fragment
p
contain
fragment
p
contain
gp
result
polyval
plasmid
p
p
recombin
virus
rescu
dna
use
helper
cell
line
describ
previous
recombin
mv
expand
cell
roller
bottl
cm
surfac
area
corn
co
accord
standard
protocol
viral
harvest
collect
differ
time
point
postinocul
viru
aliquot
store
c
ad
fb
cryoprotector
concentr
vv
viral
titer
viru
stock
determin
standard
mv
plaqu
titrat
assay
vero
cell
cultur
glass
coverslip
infect
rmvbhiv
detect
essenti
describ
previous
briefli
cell
wash
pb
fix
paraformaldehyd
permeabil
icecold
methanol
block
bsa
hiv
antigen
detect
specif
primari
antibodi
follow
alexa
secondari
antibodi
protein
also
detect
western
blot
briefli
day
postinfect
cell
wash
subsequ
lyse
l
lysi
buffer
mm
mm
trishcl
ph
contain
proteas
inhibitor
cocktail
complet
mini
roch
diagnost
gmbh
total
cell
extract
resolv
nupag
bistri
gel
invitrogen
presenc
mopscontain
run
buffer
protein
transfer
nitrocellulos
membran
semidri
blot
clade
b
hiv
antigen
detect
use
antisera
direct
hiv
addit
mv
nucleocapsid
n
phosphoprotein
p
detect
specif
antiserum
infect
cell
monolay
fix
paraformaldehyd
permeabil
methanol
stain
specif
antibodi
extens
wash
horseradish
peroxidaseconjug
secondari
antibodi
follow
seramunblu
tmbsubstrat
solut
incub
seramun
diagnost
ad
syncytia
final
analys
microscop
count
statist
relev
antibodi
hiv
antigen
kindli
obtain
aid
research
refer
reagent
program
divis
aid
niaid
nih
goat
antiserum
item
rabbit
antiserum
item
addit
mous
antimv
n
p
serum
kindli
obtain
dr
f
wild
inserm
franc
appli
follow
secondari
antibodi
use
antigoat
igg
alexa
antibodi
invitrogen
antirabbit
igg
alexa
antibodi
invitrogen
antimous
antigoat
antirabbit
hrp
dako
growth
rmv
evalu
confluent
cell
infect
medium
collect
daili
interv
dynam
viru
shed
determin
use
standard
mv
plaqu
titrat
assay
transgen
mice
lack
receptor
express
human
receptor
humanlik
tissu
specif
ifnar
employ
mv
infect
humor
immun
respons
analysi
mice
n
intraperiton
ip
immun
age
week
parent
recombin
rmvbhiv
clade
b
dosag
pfu
indic
blood
collect
week
serum
sampl
heat
inactiv
min
store
c
use
analysi
cellular
immun
respons
singl
immun
pfu
per
anim
perform
anim
kept
optim
hygien
condit
accord
swiss
anim
welfar
regul
berna
biotech
ltd
anim
facil
elisa
assay
antimv
antibodi
titer
determin
accord
standard
protocol
antihivenv
clade
b
igg
titer
determin
use
commerci
elisa
assay
kit
genscreen
elisa
kit
biorad
valu
cutoff
background
level
mean
valu
sera
control
mice
multipli
factor
three
consid
posit
titer
depict
log
reciproc
enddilut
elispot
assay
elispot
assay
perform
accord
manufactur
instruct
elispot
set
bd
bio
scienc
duplic
splenocyt
cultur
subsequ
restimul
either
equal
volum
medium
neg
control
medium
contain
modifi
vaccinia
ankara
mva
moi
medium
supplement
mvagag
moi
kindli
given
dr
garber
emori
atlanta
usa
mva
mvagag
virus
cell
incub
h
c
co
wash
step
detect
antibodi
biotinyl
antimous
antibodi
bd
bioscienc
incub
h
room
temperatur
peroxidaseconjug
streptavidin
streptavidinhrp
bd
bioscienc
use
prior
spot
develop
aec
substrat
reagent
set
bd
bioscienc
spot
count
dissect
microscop
pseudochalleng
two
group
mice
preimmun
pfu
two
group
mice
kept
naiv
control
day
postimmun
two
group
mice
one
preimmun
one
naiv
challeng
pfu
rvacgag
administ
intranas
two
group
challeng
vacwt
viru
weight
loss
monitor
daili
transgen
code
env
gag
gagpol
polyprotein
insert
either
posit
measl
p
gene
posit
measl
h
l
gene
gener
set
antigenom
plasmid
p
fig
construct
plasmid
success
rescu
calciumphosph
cotransfect
cell
line
result
recombin
express
two
transgen
virus
success
rescu
rmvbhiv
express
multipl
hiv
gene
env
gag
pol
increas
viral
genom
suggest
mv
genom
capac
toler
larg
gene
segment
virus
purifi
human
diploid
cell
three
round
serial
enddilut
expand
use
roller
flask
techniqu
recombin
virus
produc
approxim
equal
end
titer
tabl
result
suggest
insert
singl
doubl
transgen
mv
genom
markedli
affect
propag
effici
viru
transgen
express
assay
immunofluoresc
hivenv
gag
gagpol
gp
monitor
use
specif
antibodi
result
show
newli
gener
virus
specif
express
correspond
transgen
fig
protein
also
detect
western
blot
fig
expect
migrat
protein
match
expect
molecular
weight
secret
deriv
antigen
lack
hypervari
loop
migrat
lower
molecular
wt
contain
variabl
loop
context
bival
virus
env
protein
also
express
slightli
lower
level
like
due
slight
delay
viru
propag
estim
molecular
weight
kda
precursor
kda
unprocess
gagpol
polyprotein
estim
molecular
weight
kda
experiment
confirm
indic
proper
express
entir
gagpol
polyprotein
crossreact
observ
mvb
infect
cell
extract
fig
probe
equival
blot
antiserum
recogn
mv
nucleocapsid
n
phosphoprotein
p
confirm
similar
degre
replic
divers
virus
includ
parent
mvb
cell
cultur
fig
lower
panel
recombin
mvbhiv
express
either
one
transgen
show
similar
growth
compar
parent
mvbv
cell
fig
growth
kinet
recombin
viru
express
simultan
env
deriv
gp
display
slightli
slower
growth
approxim
h
like
due
overal
increas
genom
size
approxim
similarli
growth
kinet
doubl
recombin
express
env
gagpol
gp
roller
bottl
show
slight
growth
delay
kinet
end
titer
final
harvest
compar
tabl
possibl
largescal
product
vaccin
adjust
harvest
time
would
enough
yield
compar
titer
virus
stabl
shown
immunofluoresc
western
blot
fig
determin
whether
stabil
protein
express
confirm
genet
recombin
serial
passag
time
cell
amplif
factor
ten
singl
syncytia
pick
passag
genom
viral
rna
sequenc
rtpcr
result
show
genom
ten
syncytia
passag
reveal
ident
nucleotid
sequenc
origin
seed
viru
shown
immunocytochemistri
also
confirm
stabil
hivtransgen
express
passag
fig
found
titer
rmvhiv
passag
dramat
differ
yet
remain
compar
nevertheless
growth
phenotyp
observ
test
abil
rmvbhiv
vector
elicit
immun
respons
transgen
mice
suscept
mv
infect
intraperiton
ip
immun
primeboost
schedul
week
week
respect
mice
immun
singl
rmvhiv
mix
two
differ
recombin
recombin
express
doubl
transgen
standard
mvb
vaccin
use
control
blood
drawn
week
sera
assay
elisa
antibodi
respons
mv
clade
b
result
show
mous
group
immun
differ
rmvhiv
induc
similar
hightit
antimeasl
antibodi
compar
antibodi
titer
induc
standard
mvb
vaccin
fig
interestingli
probe
sera
antihiv
antibodi
compar
high
titer
antihiv
env
antibodi
found
differ
mous
group
whether
immun
singl
recombin
express
mous
group
immun
rmvhiv
express
doubl
antigen
gp
group
immun
mixtur
two
singl
recombin
fig
four
week
prime
consider
titer
anti
hiv
antibodi
readili
measur
fig
right
panel
red
bar
four
week
boost
increas
hiv
antibodi
titer
measur
mous
group
except
mvbv
immun
anim
neg
control
result
indic
rmv
vector
immunogen
presenc
antimv
antibodi
previous
induc
prime
left
panel
red
bar
rmv
express
hiv
antigen
boost
anti
hiv
antibodi
fig
right
panel
blue
green
bar
uv
inactiv
induc
detect
antibodi
env
indic
vivo
replic
central
present
env
antigen
induct
immun
respons
tabl
similarli
antivector
respons
found
sever
affect
uv
inactiv
indic
viru
replic
requir
effici
humor
immun
respons
elispot
assay
perform
measur
gagspecif
cell
activ
immun
mice
fig
splenocyt
extract
week
singl
immun
pfuanim
use
divers
viru
prepar
express
gag
gagpol
recombin
protein
splenocyt
restimul
either
medium
neg
control
mvagag
clade
b
mvagag
restimul
splenocyt
reveal
signific
cell
immun
respons
activ
mice
immun
singl
recombin
virus
express
transgen
posit
induc
best
respons
result
also
show
independ
subgenom
site
gagpol
transgen
express
posit
within
mv
genom
respect
similar
cellular
immun
respons
could
induc
moreov
doubl
recombin
virus
mix
two
recombin
virus
display
compar
cellular
immun
respons
unexpectedli
mix
gp
doubl
recombin
gp
gave
lower
number
spotform
cell
sfc
compar
singl
recombin
yet
anim
immun
amount
virus
like
virus
heterogen
mixtur
may
give
rise
unpredict
competit
two
virus
addit
delay
replic
doubl
recombin
may
also
explain
obtain
lower
valu
mvbv
vaccin
mice
expect
induc
gagspecif
cellular
immun
respons
determin
qualiti
cellular
immun
respons
induc
challeng
immun
mice
rvacgag
vacwt
ifnar
tgmice
optim
sensit
recombin
vaccinia
challeng
character
weight
loss
upon
infect
either
rvacgag
vacwt
virus
group
naiv
preimmun
mice
challeng
rvacgag
vacwt
day
postimmun
anim
weight
loss
monitor
daili
result
shown
fig
indic
preimmun
mice
less
suscept
weight
loss
mice
indic
control
replic
challeng
viru
one
group
anim
preimmun
challeng
vacwt
display
signific
weight
loss
day
postchalleng
naiv
mice
challeng
either
rvacgag
vacwt
display
fast
weight
loss
respect
result
obtain
suggest
induc
function
cell
immun
protect
immun
anim
recombin
vacgag
mice
immun
naiv
group
split
group
day
later
two
group
challeng
wildtyp
vaccinia
vacwt
recombin
vaccinia
express
vacgag
dot
repres
anim
gp
gener
recombin
mv
express
antigen
independ
open
read
frame
insert
either
p
gene
h
l
gene
mv
genom
demonstr
previous
effect
rmvb
vector
siv
sarscov
manuscript
demonstr
express
hiv
antigen
remain
genet
stabl
serial
passag
cell
shown
immunocytochemistri
sequenc
replic
kinet
rmvhiv
follow
trend
parent
mvb
vaccin
behaviour
particularli
favour
rmvb
vaccin
candid
member
suggest
high
fidel
mv
rna
polymeras
plastic
mv
abil
stabli
express
foreign
gene
gene
studi
multipl
passag
suggest
mv
robust
superior
deliveri
system
comparison
rna
viru
vector
unlik
mv
mani
rna
virus
unabl
accommod
larg
foreign
sequenc
icosahedr
capsid
often
rapidli
lose
even
small
insert
due
depend
rna
secondari
tertiari
structur
well
high
level
recombin
mvbbase
system
sever
advantag
live
viral
vector
use
mv
strain
alreadi
use
safe
efficaci
vaccin
product
cost
standard
mv
vaccin
low
current
mv
vaccin
wellknown
induc
lifelong
immun
demonstr
rmvhiv
candid
vaccin
product
upscal
end
viru
titer
compar
standard
mv
vaccin
furthermor
parent
recombin
mvb
virus
shown
induc
compar
antimv
immun
respons
featur
particularli
import
mass
immun
envisag
develop
countri
regard
use
mv
vector
cocktail
deliv
simultan
sever
addit
antigen
could
envisag
instead
routin
mv
vaccin
earli
childhood
develop
effect
hiv
vaccin
remain
challeng
endeavour
howev
complex
may
due
deliveri
system
per
se
due
heterogen
demonstr
mv
vector
induc
humor
cellular
immun
respons
experiment
anim
induct
cellular
immun
respons
shown
protect
anim
high
dose
recombin
vaccinia
viru
challeng
indic
induc
cellular
immun
respons
function
protect
least
small
anim
model
system
